Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Inspire Medical Systems (INSP) Change in Inventory (2017 - 2025)

Historic Change in Inventory for Inspire Medical Systems (INSP) over the last 9 years, with Q4 2025 value amounting to $3.5 million.

  • Inspire Medical Systems' Change in Inventory fell 7228.44% to $3.5 million in Q4 2025 from the same period last year, while for Dec 2025 it was $65.2 million, marking a year-over-year increase of 4097.07%. This contributed to the annual value of $65.2 million for FY2025, which is 4097.07% up from last year.
  • As of Q4 2025, Inspire Medical Systems' Change in Inventory stood at $3.5 million, which was down 7228.44% from $20.1 million recorded in Q3 2025.
  • Inspire Medical Systems' 5-year Change in Inventory high stood at $21.9 million for Q2 2025, and its period low was -$6.7 million during Q3 2022.
  • For the 5-year period, Inspire Medical Systems' Change in Inventory averaged around $6.8 million, with its median value being $5.1 million (2022).
  • Its Change in Inventory has fluctuated over the past 5 years, first plummeted by 39447.13% in 2022, then surged by 161374.27% in 2023.
  • Over the past 5 years, Inspire Medical Systems' Change in Inventory (Quarter) stood at $1.7 million in 2021, then crashed by 296.68% to -$3.3 million in 2022, then skyrocketed by 338.45% to $7.8 million in 2023, then surged by 63.25% to $12.7 million in 2024, then crashed by 72.28% to $3.5 million in 2025.
  • Its Change in Inventory was $3.5 million in Q4 2025, compared to $20.1 million in Q3 2025 and $21.9 million in Q2 2025.